SODIUM PHOSPHATE, DIBASIC

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
96.0 -2.2 1 3 83.0 0 0.0
CAS
10140655
UNII
GR686LBA74
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Im - Iv Injectable 1.74%
Im - Iv Injection
Im - Iv Powder, For Injection Solution 4%
Intradermal Injection 0.2%
Intralesional Suspension, Injection 0.14%
Intramuscular Injectable 0.35%W/V
Intramuscular Injection 0.48%
Intramuscular Suspension, Injection 0.14%
Intrasynovial Suspension, Injection 0.14%
Intravenous Injectable 4%
Intravenous Injection 0.76%
Intravenous Solution, Injection 0.11%
Iv(infusion) Injection
Iv(infusion) Powder, For Injection Solution 4%
Iv(infusion) Powder, For Injection Solution, Lyophilized 0.38%
Nasal Spray
Nasal Spray, Metered 0.3%
Ophthalmic Solution 0.29%
Ophthalmic Suspension 0.43%
Oral Concentrate 0.34%
Oral Solution 0.95%
Oral Suspension 0.45%
Oral Syrup 0.27%
Soft Tissue Suspension, Injection 0.14%
Subcutaneous Injection 0.14%
Subcutaneous Powder, For Injection Solution, Lyophilized 0.3%
Subcutaneous Suspension, Injection 0.09%
Topical Emulsion, Cream 0.1%
Topical Ointment 0.03%W/W

More Information

Usage Over Time

Comments